The historical rank and industry rank for Kiromic BioPharma's Net Margin % or its related term are showing as below:
KRBP's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.15 * Ranked among companies with meaningful Net Margin % only.
Kiromic BioPharma Net Margin % Historical Data
The historical data trend for Kiromic BioPharma's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kiromic BioPharma's Net Margin %
For the Biotechnology subindustry, Kiromic BioPharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kiromic BioPharma's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kiromic BioPharma's Net Margin % distribution charts can be found below:
* The bar in red indicates where Kiromic BioPharma's Net Margin % falls into.
Kiromic BioPharma Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Kiromic BioPharma's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kiromic BioPharma (OTCPK:KRBP) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Kiromic BioPharma Net Margin % Related Terms
Thank you for viewing the detailed overview of Kiromic BioPharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Kiromic BioPharma (Kiromic BioPharma) Business Description
Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRBP has been successfully added to your 